Clinical Trial Update: The Potential Protective Role of Venlafaxine Versus Memantine in Paclitaxel Induced Peripheral Neuropathy [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating venlafaxine versus memantine for protection against paclitaxel-induced peripheral neuropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy
• Oncology Pain

Drugs mentioned

• Memantine (memantine)
• Venlafaxine (Venlafaxine)

Snippet

Sponsor: Mendel AI | Conditions: Oncology Pain, Chemotherapy-induced Peripheral Neuropathy | Phase 2, Phase 3 | Status: UNKNOWN